TislelizumabCytokine release syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2041卷 / 1期

关键词：

D O I：

10.1007/s40278-025-74774-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：385 / 385

相关论文

共 50 条

[41] Pertuzumab/trastuzumabCytokine release syndrome: case report
Reactions Weekly, 2018, 1709 (1) : 204 - 204
[42] NivolumabHypothyroidism and cytokine release syndrome: case report
Reactions Weekly, 2021, 1869 (1) : 288 - 288
[43] NivolumabCytokine-release syndrome: case report
Reactions Weekly, 2018, 1721 (1) : 211 - 211
[44] Blinatumomab/ponatinibCytokine release syndrome: case report
Reactions Weekly, 2021, 1857 (1) : 81 - 81
[45] Ipilimumab/nivolumabCytokine release syndrome: case report
Reactions Weekly, 2023, 1950 (1) : 230 - 230
[46] NivolumabParadoxical cytokine release syndrome: case report
Reactions Weekly, 2021, 1886 (1) : 322 - 322
[47] CotrimoxazoleCytokine release syndrome and neutropenia: case report
Reactions Weekly, 2022, 1909 (1) : 193 - 193
[48] PembrolizumabAcute cytokine release syndrome: case report
Reactions Weekly, 2021, 1882 (1) : 398 - 398
[49] NivolumabMild cytokine release syndrome : case report
Reactions Weekly, 2024, 2021 (1) : 428 - 428
[50] TisagenlecleucelCytokine release syndrome and myelitis: case report
Reactions Weekly, 2020, 1819 (1) : 269 - 269

← 1 2 3 4 5 →